UPDATE: Morgan Stanley Reiterates On WuXi PharmaTech As Strong Growth Remains Intact

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

In a report published Friday, Morgan Stanley analyst Bin Li reiterated an Overweight rating on WuXi PharmaTech (NYSE: WX), but removed the $45.00 price target.In the report, Morgan Stanley noted, “WX's share price dropped 9% yesterday – in our view, the market has overreacted to its 1Q14 results that contained FX losses. 1Q14 non-GAAP EPS of $0.40 excl. FX impact and other gain beat our est. by 7% due to better sales and margins. Mgmt raised its 2014 bottom-line guidance by $0.05 on higher sales growth and improved productivity. We believe the stock is attractive, trading at 16x 2014e EPS. Reiterate OW.”WuXi PharmaTech closed on Thursday at $33.05.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!